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Timely Topics in Nutrition
In December 2005, 2 dogs died of acute hepatic
failure after consuming a commercially available food
formulated for dogs. Food toxicosis was suspected.
The product manufacturera was notified by the attend-
ing veterinarian, and necropsy of the dogs was per-
formed by a university pathology service. Product date
codes for the product consumed by the dogs were not
provided to the manufacturer, and the FDA was not
notified of potential product contamination. Screening
of raw ingredients and finished product to detect afla-
toxin by the manufacturer yielded negative results. 
However, additional dogs in the eastern United
States developed clinical signs of suspected toxicosis.
These additional animals, along with the product
description and date code, were reported to the prod-
uct manufacturer. The FDA was notified of the possi-
ble toxicosis, and testing confirmed contamination
with aflatoxin. The manufacturer issued a recall of 19
products produced at a plant in South Carolina.1 After
the manufacturer conducted additional extensive test-
ing of samples of finished products, the list of products
and potentially affected lots was narrowed to specific
production and use-by dates.1,2 Recall instructions
advised pet owners to discontinue feeding the product
and to return bags of food to their retailer. Concerned
pet owners were instructed to consult a veterinarian if
their dog had clinical signs that included loss of
appetite; yellow coloration of the whites of the eyes,
gums, or skin in the belly or other areas where the hair
is thin; severe, persistent vomiting combined with
bloody diarrhea; discolored urine; and fever.
As consumers and veterinarians became informed
about the contamination, the number of reported dogs
in the eastern United States increased rapidly. Internet-
based discussions on a general veterinary Web site3 and
list servers for recognized veterinary specialty organi-
zations facilitated communication and sharing of rec-
ommendations on monitoring, testing, and treating
affected dogs. Despite the timely recognition of the
toxicity and dissemination of information, > 100 dogs
apparently died as a result of the toxic effects of conta-
minated products.4 This highlights the need for veteri-
narians to rapidly recognize adverse events involving
consumption of contaminated foods; contact the
appropriate groups involved (eg, retailers, product
manufacturers, and regulatory agencies); and retain
suitable food samples, product labels, and biological
samples to aid in the identification of contaminated
foods, rapid notification of pet owners, and documen-
tation for clients. 
Clinical Signs of Aflatoxicosis
Eight dogs were examined or necropsied (or both)
at the University of Tennessee College of Veterinary
Medicine and confirmed to have aflatoxicosis linked to
consumption of a commercially availablea food formu-
lated for dogs. Review of the information for these 8
dogs provides a spectrum of the medical history, clini-
cal signs, and progression of disease seen with afla-
toxicosis. In addition, 4 other dogs with suspected 
aflatoxicosis were evaluated or necropsied at the uni-
versity. However, aflatoxicosis could not be confirmed
in those 4 dogs because of atypical clinical signs or
pathologic characteristics and lack of evidence for tox-
icologic exposure (eg, lack of food samples or product
date codes or negative results for analysis of food and
tissues). Therefore, the information provided here does
not include data for those 4 suspect dogs. 
The 8 dogs consisted of 6 Basset Hounds, 1
Australian Shepherd, and 1 Airedale Terrier. These
dogs had a median age of 2 years. The Australian
Shepherd died at home after a 4-day episode of lethar-
gy, anorexia, and vomiting that had progressed to
icterus, melena, and hematemesis. Hematologic testing
conducted by the referring veterinarian confirmed that
the dog had increases in hepatic enzyme activity and
total bilirubin concentration. A necropsy was per-
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formed on the Australian Shepherd. A seventh Basset
Hound from the same household had also died after an
episode of an acute onset of lethargy, anorexia, icterus,
gingival petechial hemorrhages, and increased ALT
activity, as determined by testing conducted by the
referring veterinarian. Although a necropsy was not
performed on this Basset Hound, subsequent analysis
of the food fed to the dogs of that household support-
ed a diagnosis of aflatoxicosis. 
Historically, several affected dogs had a decrease in
interest in consuming the food prior to the knowledge
that it was contaminated, which was suggestive of
altered palatability of the diet. Three of the 7 dogs
examined at the university were sick at the time of ini-
tial examination, with signs of lethargy, anorexia, vom-
iting, melena, and icterus. Four Basset Hounds, which
comprised half of the 8 dogs in which aflatoxicosis was
definitively confirmed, did not have clinical signs at
the time of our initial evaluation and were examined
because of the death of the aforementioned Basset
Hound and 2 ill Basset Hounds from the same house-
hold. Analysis of results of laboratory testing conduct-
ed at the time of initial examination confirmed that all
7 dogs examined (including the 4 dogs that did not
have clinical signs of aflatoxicosis) had variable
increases in activity of ALT (range, 269 to 2,259 U/L;
median, 803 U/L; reference range, 25 to 106 U/L) and
AST (range, 75 to 1,090 U/L; median, 148 U/L; refer-
ence range, 16 to 50 U/L), hyperbilirubinemia (total
bilirubin concentration; range, 0.3 to 8.6 mg/dL; medi-
an, 1.4 mg/dL; reference range, 0.1 to 0.2 mg/dL), and
a prolonged prothrombin time (32 to > 70 seconds;
median, 52 seconds; reference range, 10.0 to 16.8 
seconds). 
Treatment and Outcome
All 7 dogs received supportive treatment by IV
administration of an electrolyte solutionb that con-
tained supplemental potassium chloride.c Dogs also
were administered S-adenosylmethionine,d milk this-
tle,e vitamin K1,
f ampicillin,g famotidine,h sucralfate,i
nutritional support via total parenteral nutrition, and
transfusions of fresh-frozen plasma. The condition of
the Airedale Terrier quickly deteriorated, which led us
to euthanatize the dog within 12 hours after initial
examination, and the 2 ill Basset Hounds died within 3
days after initial examination at our university facility. 
Despite the aggressive treatment early during the
course of the condition, clinical signs (anorexia,
icterus, vomiting, melena, and severe peripheral
edema) developed in all 4 remaining Basset Hounds
within 8 days of our initial examination during admis-
sion. Clinical signs corresponded with progression of
increases in ALT and AST activities, hyperbilirubine-
mia, hypoalbuminemia, hypocholesterolemia, and
severe coagulopathy. Three of the 4 dogs died or were
euthanatized within 2 days after onset of clinical signs.
The last of the Basset Hounds that developed clinical
signs was a 2-year-old sexually intact male that had
been receiving a restricted amount of the contaminat-
ed food because of the dog’s inclusion in a weight-loss
program. This dog had a slower progression of changes
in laboratory variables and was the final dog to devel-
op clinical signs on day 8 after admission. Despite con-
tinued aggressive supportive care, the dog’s condition
worsened during the subsequent 7 days and this final
Basset Hound was euthanatized on day 15 after 
admission.
Necropsy Findings
Necropsies were performed on all 8 dogs with con-
firmed aflatoxicosis. All had severe icterus of the
mucous membranes and sclera. Hepatomegaly and a
diffuse yellow friable appearance of the liver were con-
sistently identified. Six of 8 dogs had severe acute
edema and hemorrhage in the subcutaneous tissues as
well as intestinal hemorrhage. Four dogs had systemic
petechiae, 4 had gastric ulcers with melena, and 3 had
reactive femoral bone marrow. 
Histologic lesions were similar in all dogs but 
varied in extent and duration. Marked cytoplasmic vac-
uolar degeneration consistent with accumulation of
hepatocellular lipids was evident in all 8 dogs. Portal
fibrosis was identified in 7 dogs, and 7 dogs had biliary
hyperplasia. Hepatocellular cholestasis was detected in
all 8 dogs. Inflammation with primarily lymphocytes was
identified in the portal triads of 7 dogs, and scattered
hepatocyte necrosis was identified in 4 dogs. Lesions of
lesser importance included sinusoidal extramedullary
hematopoiesis in 4 dogs, nodular hyperplasia in 2 dogs,
and arterialization of central veins in 3 dogs. 
Aflatoxins
Aflatoxins are a group of related, natural, toxic by-
products of the fungi Aspergillus flavus, Aspergillus par-
asiticus, and a few select Penicillium spp, which are
ubiquitous soil contaminants found throughout the
world. These fungal organisms grow on most natural
products, including corn, peanuts, rice, soybeans,
wheat, and oats.5 Aflatoxin production results when
there are specific environmental temperatures and
moisture conditions, and risk of contamination is
increased when crops are stressed by drought, insect
damage, improper field management, or inappropriate
handling or storage.5
Four natural aflatoxins (B1, B2, G1, and G2) are
responsible for food contamination, with B1 being the
most hepatotoxic. Aflatoxins also can be immunosup-
pressive, nephrotoxic, and carcinogenic, and they can
cause hemolytic anemia and coagulopathies.6-9
Aflatoxins are liposoluble and readily absorbed from
the gastrointestinal tract into the portal blood.8 They
are then transported to the liver for metabolism.
Toxicosis is a result of binding of essential enzymes,
which blocks DNA polymerase and ribosomal translo-
case and causes formation of DNA adducts.8
Dogs and cats are especially susceptible to the
toxic effects of aflatoxin B1 in feed (> 60 μg/kg of feed)
with an LD50 of 0.5 to 1.5 mg/kg of body weight for
dogs and 0.3 to 0.6 mg/kg for cats.6 There is a dose-
response correlation with survival time and intensity of
histologic changes.10 Rate of metabolism varies on the
basis of genetics, age, hormonal status, nutritional sta-
tus, and concurrent disease, with young animals and
animals that are pregnant being the most susceptible to
the toxic effects of aflatoxins.5,8,11
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Aflatoxin Contamination
All corn and corn products are routinely tested for
aflatoxin contamination prior to their use in the man-
ufacture of commercial food formulated for dogs. Corn
is often screened for fluorescence by use of a 365-nm
black light prior to its sale to manufacturers and again
by the manufacturer prior to being unloaded from
trucks. Fluorescence screening is a presumptive test for
aflatoxins and is based on the natural bright greenish-
yellow fluorescence of kijic acid produced by the fungi,
which signifies fungal growth. However, this test can-
not be used to quantify the amount of toxin.12
Aflatoxins are not evenly distributed throughout each
load of contaminated corn, which allows false-negative
results during routine screening tests. 
A more definitive test uses HPLC to detect and pro-
vide a range of aflatoxin contamination. The FDA
encourages but does not require HPLC testing; however,
the FDA does require that food manufactured for con-
sumption by humans and dogs must contain < 20 μg 
of aflatoxin/kg of food. 
For the situation described here, the FDA conclud-
ed on January 19, 2006, that the company did not
appropriately adhere to its own stringent guidelines for
aflatoxin testing for 12 shipments of corn that arrived at
the plant in South Carolina in September and October
of 2005.2 Food manufactured for dogs between October
1 and 15, 2005, was contaminated, and the final food
product was shipped from this plant to retailers in 
23 states and at least 29 countries.1 To minimize the risk
of aflatoxin contamination in the future, the manufac-
turer has strengthened premanufacturing monitoring 
of incoming corn and added additional testing of the
final product to their safety protocols.1
Prevention of Aflatoxicosis
Because aflatoxin contamination can be found
sporadically throughout corn in shipments, and small
amounts can potentially escape detection despite regu-
lar monitoring, researchers have investigated methods
to prevent gastrointestinal absorption of aflatoxins. A
promising prospect is the addition of dietary clay to
dry diets during the extrusion process or as a coating
on the surface of the kibble.13 Addition of hydrated
sodium calcium aluminosilicate, a clay that tightly and
selectively adsorbs aflatoxins, is effective in protecting
dogs fed aflatoxin-contaminated foods.13 In the future,
the addition of this clay may provide the pet food
industry with a means to further ensure the safety of
foods formulated for pets. 
Diagnosis and Documentation 
of Aflatoxicosis 
Historical evidence of exposure and results of lab-
oratory tests, including an increase in ALT activity,
hyperbilirubinemia, hypocholesterolemia, and pro-
longed clotting times, support a clinical diagnosis of
aflatoxicosis. Further supportive diagnostic test results
include low concentrations of antithrombin III and low
activity of serum protein C. Samples for measurement
of concentrations of antithrombin III can be submitted
to a specific veterinary diagnostic laboratory.j Deter-
mination of protein C activity is available at another
veterinary diagnostic laboratoryk and has proved
promising for use as a sensitive screening test for afla-
toxicosis, although the assay is not specific because
activity of protein C may decrease in response to expo-
sure to any hepatotoxin.
Concentrations of the M1 metabolite of aflatoxin B1
in urine samples have been measured by use of HPLC in
research settings for documenting aflatoxicosis and
monitoring affected animals. However, this metabolite is
cleared from the body within 48 hours after ingestion.13
Therefore, testing of urine samples may be worthwhile
for dogs suspected of aflatoxin exposure that are still
consuming the diet, but it is not appropriate as a screen-
ing test for dogs whose diet has been changed because of
suspected food contamination. 
Histologic lesions in liver samples obtained during
biopsy procedures or necropsy can help confirm afla-
toxicosis. Additional confirmation can be obtained by
submitting serum or liver samples for aflatoxin testing.
In the situation described here, samples of liver from
each of the 8 dogs were submitted for analysis of afla-
toxin metabolite (M1) and results confirmed high
amounts of aflatoxin in 7 of the 8 livers.l
Saving a sample of the suspect food as well as
packaging information, including the product and date
code, is a critical component of documenting food con-
tamination and aiding manufacturers in identifying
and isolating the contaminated lots (Figure 1). Pet
owners may be encouraged to keep food for their pets
in the original packaging, rather than transferring food
into a separate storage container. The owner of the
Basset Hounds described here saved a sample of food
and a package label indicating the manufacturing plant
and use-by date involved in the recall. The sample of
food had positive results when tested for aflatoxin B1
(579 μg/kg), aflatoxin B2 (19 μg/kg), and total aflatox-
in (598 μg/kg). The toxic range for total aflatoxin con-
centration is > 60 μg/kg of feed.j The food fed to the
Airedale Terrier also had positive results when tested
for total aflatoxin (223 μg/kg).k
Providing pet food manufacturers with a clinical
diagnosis and detailed description of the suspected
product, date codes, and consumption data will help to
focus analytic testing to the most likely contaminant
and help them to more rapidly identify affected lots of
product. Working in conjunction with pet food manu-
facturers typically results in the rapid identification
and resolution of food contamination issues. 
Figure 1—Photograph of the date code and product code
obtained from a package of food fed to 7 Basset Hounds in the
same household, all of which subsequently developed clinical
signs of aflatoxicosis. This is an example of the packaging mate-
rial that should be saved for use in product identification when
contaminated food is suspected.
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Recognizing Food Contamination
Most episodes of contaminated commercially
manufactured pet foods are evident as a geographic
and temporal cluster of cases within the same house-
hold, kennel, or area. The clustered cases are sugges-
tive of an infectious disease or exposure to toxins, and
obtaining a thorough medical history may help limit
the list of initial differential diagnoses. In the dogs
described here, leptospirosis was considered as a pri-
mary differential diagnosis for the 1 dead and 2 ill
Basset Hounds prior to discovery of aflatoxin contami-
nation. However, PCR assay for leptospires yielded
negative results. A history of recent feeding from a new
bag of food, recent changes in diet, signs of altered
food palatability, or decreased appetite are all consis-
tent with a contaminated food. The index of suspicion
for a contaminated food is further increased when mul-
tiple households with affected dogs feed the same diet,
although not all dogs consuming that diet will neces-
sarily have clinical signs or be affected. 
Identifying Toxins in Foods
Once a toxin is suspected, an epidemiologic inves-
tigation is initiated to identify the unknown toxin or
toxins and appropriately deal with the situation. A
checklist of components is suggested for use in helping
veterinarians identify and document disease caused by
contaminated foods (Appendix). A toxin-oriented
approach can be used when exposure to a particular
toxin is known or suspected and tests can quickly be
conducted to verify that toxin. More often, the toxin or
toxins are unknown, and investigators must use a dis-
ease-oriented approach that involves recognized clini-
cal signs to identify the suspect toxin and then confirm
the underlying cause. Steps in this investigation
include a descriptive phase, generation and testing of a
hypothesis, and confirmatory testing.14 The descriptive
phase involves creating a case definition as well as
describing signalment of affected patients, changes in
laboratory test results for specific variables, results of
histologic examination, and patterns of disease pro-
gression. Generation and testing of a hypothesis is con-
ducted on the basis of known toxins that may cause the
clinical findings and appropriate documentation from
toxicologic testing of the blood or tissues of affected
animals. When a toxin can be identified during analy-
sis of a patient’s sample, and exposure to that toxin is
consistent with the clinical signs, confirmation testing
of the suspect food should be performed to establish a
causal relationship. 
Contacting the Appropriate Groups 
about Suspected Food Contamination
As soon as food contamination is suspected, vet-
erinarians should contact the manufacturer of the
product. Veterinarians should also contact the FDA
when the dietary history and medical evaluation are
consistent with food contamination. Samples of food
should be obtained from pet owners for testing, and
packaging information should be obtained, if possi-
ble. Veterinarians should maintain medical records
documenting clinical signs and laboratory test
results consistent with the suspected contamination.
Veterinarians can submit samples to veterinary diag-
nostic laboratories or toxicology laboratories for test-
ing, but it is not necessary to await laboratory test
results prior to contacting the aforementioned
groups. Although suspected food toxicoses reported
by pet owners are often subsequently found to be
incorrect, appropriately documented cases reported
by veterinarians are highly credible. 
Once contacted, the manufacturer and FDA will
perform additional testing to quickly confirm or dis-
prove the suspected contamination and decide whether
a product recall is indicated. The manufacturer should
then communicate via the media to inform veterinari-
ans and consumers of the potential contamination as
well as to provide recommendations for recall and 
procedures for reporting possible cases. Timely dis-
semination of knowledge is critical during food conta-
mination episodes to minimize additional exposures
and allow for appropriate screening and treatment to
begin as soon as possible. 
State veterinarians and state, regional, and local
veterinary medical associations can help notify veteri-
narians. Each veterinarian can then inform their clients
of the recall and provide medical advice. Retailers of
the food products also play a large role in providing
information to pet owners and reminding them to save
samples of suspected food as well as labels from sus-
pected food products. It is important that all authorita-
tive groups or people involved report only known facts
and provide sound and justifiable advice to consumers
to avoid unnecessary panic or alarm. 
In the aflatoxin-contamination episode that affect-
ed > 100 dogs, the Internet became an extremely useful
modality for communication among veterinarians.
Various professional list servers and a general veterinary
Web site3 were excellent sources for up-to-date infor-
mation as the epidemiologic investigation progressed,
which helped further develop the case definition and
document the progression of the condition in affected
dogs. Use of the general veterinary Web site3 also
allowed open discussion among veterinarians employed
by corporations or the pet food industry, veterinarians
in general practice, and board-certified veterinary spe-
cialists so that timely and appropriate recommenda-
tions for diagnostic testing and treatment protocols
could be developed. However, despite good intentions
by all contributors, it should be remembered that
Internet discussions do not represent peer-reviewed
publication; thus, caution must be used to avoid dis-
semination of misinformation. 
Submitting Samples for Analysis
A veterinary diagnostic toxicologist can be con-
tacted to help clinicians narrow the list of potential
toxins and determine the appropriate samples for sub-
mission. Samples of whole blood (collected into tubes
containing EDTA as an anticoagulant), serum, urine,
fresh or frozen tissues, gastrointestinal contents, and
food are all commonly requested in cases of suspected
food contamination. As soon as the association
between the illness and contaminated food is recog-
nized, every attempt should be made to save a large
sample of the food and the entire package label (or at
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least the package label with the product code and use-
by dates). Approximately 1 kg of dry food or 4 cans of
food should be saved for testing, but a portion should
also be maintained for future reference. Food should be
frozen or stored at room temperature in an airtight bag.
Unopened cans of food should remain at room temper-
ature. Samples of fresh or frozen tissues for use in tox-
icologic analysis should be large, whereas samples
placed in formalin for histologic examination should
be thin to allow for proper penetration by the fixative.15
Samples should be submitted for analysis as soon
as possible, although weekend and holiday shipments
should be avoided. Testing laboratories can advise vet-
erinarians on shipping conditions, such as whether dry
ice is needed. Proper packaging for biohazardous mate-
rial is required. A full list of accredited veterinary diag-
nostic laboratories is provided at the American
Association of Veterinary Laboratory Diagnosticians
Web site.16 For the situation described here, food sam-
ples were submitted to 2 separate veterinary diagnostic
laboratoriesj,k and liver samples were submitted on dry
ice to another veterinary diagnostic laboratory.l
Determining Appropriate Treatment
Initial treatment for sick dogs should be based on
documented problems and tentative diagnoses. Often,
this includes nonspecific supportive care, such as in
the case of aflatoxicosis. To address hepatic damage
caused by aflatoxins, treatments include S-adenosyl-
methionine, milk thistle, vitamin K1, vitamin E, nutri-
tional support, and fresh-frozen plasma. As more infor-
mation becomes available about the contaminating
toxin or toxins, specific treatments may become an
option. It can be challenging to determine which dogs
require treatment and when to begin treatment, and
such decisions should be made on the basis of knowl-
edge about toxin behavior and discussions between
veterinarians and clients. In the dogs with aflatoxicosis
described here, many had progressive changes in labo-
ratory test results for several variables while still with-
out clinical signs of toxicosis and prognosis was guard-
ed once clinical signs developed. This suggests that
early treatment before development of clinical signs
was indicated to minimize morbidity and fatalities in
dogs known to have ingested aflatoxin-contaminated
food. Early prophylactic or therapeutic treatments are
not necessarily indicated for every patient with poten-
tial toxin exposure; thus, each animal must be assessed
separately.
Commercial Food Contaminations
Although rare, contaminations of commercial foods
formulated for dogs that result in substantial morbidity
and fatalities are seen sporadically. To our knowledge,
since 1975, there have been 11 other episodes of afla-
toxin contamination in foods manufactured for dogs.
The most recent episode was in 1998 in Texas, with 55
confirmed deaths of dogs.17 In 2003, 48 dogs (all of
which were consuming the same natural dog food)
became ill with various clinical problems, including
hepatic failure, immune-mediated hemolytic anemia,
and sudden death.18 However, despite thorough testing,
the final FDA report19 did not identify the inciting cause,
although deviation in product formula by the addition
of a synthetic antioxidant to the natural diet was discov-
ered. In early 2006, a manufacturing error in another
commercial diet was identified, with excessive amounts
of vitamin D3 cited as the cause for hypercalcemia in
dogs and cats.20 These episodes of food contamination
reinforce the need for quality-control monitoring by
food manufacturers as well as quick recognition and
action by veterinarians suspecting such a problem. 
Conclusions
Despite protective measures and protocols to
ensure safety of food components and accuracy of
recipe preparation, food contamination and misformu-
lation accidents have resulted in morbidity and fatali-
ties of animals. Veterinarians are instrumental in the
timely recognition of adverse health effects associated
with adulterated foods. Appropriate notification of
manufacturers and regulatory agencies, combined with
detailed documentation, sample collection, and analyt-
ic testing, will aid in the confirmation or rejection of a
suspected toxic exposure. 
An outbreak of aflatoxicosis was reported in at
least 100 dogs consuming a commercial food manufac-
tured in the southeastern United States. Of the dogs
examined at our university facility, 8 were confirmed
with aflatoxicosis and served to illustrate the variabili-
ty in clinical signs of acute aflatoxicosis as well as to
highlight the appropriate steps for appropriate notifi-
cation of the manufacturer and regulatory agencies,
documentation for each animal, and confirmation of
the involved toxin. Timely and appropriate handling of
situations that involve suspected contaminated com-
mercial foods will help minimize exposure, morbidity,
and fatalities of animals.
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i. Sucralfate, Aventis Pharmaceuticals, Kansas City, Mo.
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Appendix
Suggested checklist for dealing with suspected contaminated food.
• Retain food samples for analysis. 
Retain 4 cans or 1 kg of dry food, when possible.
Freeze when possible or store at room temperature in airtight bags.
• Document product name, type of product and manufacturing information.
Retain all packaging.
Identify date codes or production lot numbers.
Retain purchase receipts.
• Document product consumption.
Dates product or products were fed.
Consumption and palatability history.
Time of onset of clinical signs.
Detailed dietary history (ie, all products fed and feeding methods).
• Contact the manufacturer.
• Contact the FDA Consumer Complaints Coordinator for your state. 
A list of telephone numbers for each state is available at:
www.fda.gov/opacom/backgrounders/complain.html.
• Document communication with the FDA, manufacturer, and clients.
Record date, time, and contact person.
Maintain a unique identification number for each patient.
• Submit samples to a diagnostic laboratory, the FDA, or the manufacturer for analysis.
• Submit all deceased animals for necropsy or collect appropriate samples.
Store tissue samples in formalin as well as in a freezer.
Consult with personnel at diagnostic laboratory for required quantity of tissues, 
tissue preparation, storage conditions, and submission of samples.
• Maintain detailed medical records of affected animals.
Clearly record clinical course, diagnostic tests, treatments, and outcome. 
When possible, retain serum and tissue samples for further testing.
• Notify clients of potential exposure to contaminated foods or product recalls.
Recommend that clients discontinue feeding potentially contaminated food.
Suggest that clients always save original food packaging.
• Examine all pets with known or suspected exposure to contaminated foods.
Submit appropriate samples for diagnostic testing.
Initiate prophylactic or therapeutic treatment as indicated.
• Obtain written client authorization prior to release of medical information.
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